相关实验视频
Updated: Jul 24, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
肥胖和失脂症:对当前证据的审查
Jelena Vekic1, Aleksandra Stefanovic2, Aleksandra Zeljkovic2
1Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, Vojvode Stepe 450, P. Box 146, 11000, Belgrade, Serbia. jelena.vekic@pharmacy.bg.ac.rs.
肥胖会导致动脉脂缺血症,改变脂蛋白,增加心脏代谢风险,特别是在女性中. 先进的技术揭示了HDL变化和生殖障碍的新生物标志物.
科学领域:
- 内分泌学和新陈代谢学
- 心血管科学 心血管科学
- 脂质组学和蛋白质组学
背景情况:
- 肥胖与动脉脂缺血症有关,其特征是血脂蛋白发生变化,包括高甘油三和降低的HDL胆固醇.
- 这种脂质障碍在女性中更为普遍,造成生殖问题,妊娠并发症和长期心脏代谢疾病的风险.
研究的目的:
- 审查最近关于肥胖症失脂症的研究.
- 强调女性特异性疾病和与肥胖相关的脂质不良症相关的心脏代谢风险.
主要方法:
- 关于肥胖,脂质不良和脂质蛋白变化的当前科学文献的综述.
- 专注于高级分析技术,如蛋白质组学和脂质组学,用于生物标志物识别.
主要成果:
- 研究越来越多地集中在肥胖中脂蛋白的结构和功能修改上.
- 蛋白质和脂质学研究显著提高了对HDL变化的理解.
- 与肥胖相关的脂质不良症在多囊卵巢综合征和高风险怀孕中很普遍,但对于未来的心脏代谢影响往往没有充分研究.
结论:
- 对脂蛋白质量的更深入的理解对于管理与肥胖相关的心脏代谢疾病至关重要.
- 基于Omics的技术提供了全面的失脂症评估,以减轻心血管风险.
- 需要进一步研究与肥胖相关的女性生殖障碍,以获得临床应用.
更多相关视频
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
相关概念视频
Obesity
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents